Clinical Trials Browser

OTHER × Colorectal Cancer Metastatic × spartalizumab × Clear all

NCT04030260 2023-03-23

Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Colorectal Cancer Metastatic